Brumm Joshua T's Form 4 filing
Crescent Biopharma, Inc. (CBIO) · filed Sep 18, 2026
- Accession no.
- 0001628280-26-062701
- Filed
- Sep 18, 2026, 4:02 PM ET
- Trade date
- Sep 16-18, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $159.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Brumm Joshua TCIK 0001528826 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | Ordinary Shares | SSaleDisposed | −1,610 | $17.90 | −$28,819 | 279,602 | Direct | |
| Sep 18, 2026 | Ordinary Shares | SSaleDisposed | −7,837 | $16.71 | −$130,956.27 | 271,765 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.